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Abstract Increasingly, high-risk pregnant women opt for
non-invasive prenatal testing (NIPT) instead of invasive diag-
nostic testing. Since NIPT is less accurate than invasive test-
ing, a normal NIPT result might leave women less reassured.
A questionnaire study was performed among pregnant women
with elevated risk for fetal aneuploidy based on first-trimester
combined test (risk ≥1:200) or medical history, who were
offered NIPT in the nationwide Dutch TRIDENT study. Pre-
and post-test questionnaires (n = 682) included measures on:
experiences with NIPT procedure, feelings of reassurance,
anxiety (State-Trait Anxiety Inventory, STAI), child-related
anxiety (PRAQ-R), and satisfaction. The majority (96.1%)
were glad to have been offered NIPT. Most (68.5%) perceived
the waiting time for NIPT results (mean: 15 days, range 5–32)
as (much) too long. Most women with a normal NIPT result
felt reassured (80.9%) or somewhat reassured (15.7%). Levels
of anxiety and child-related anxiety were significantly lower
after receiving a normal NIPT result as compared to the mo-
ment of intake (p < 0.001). Women with inadequate health
literacy or a medical history (e.g. previous child with trisomy)
experienced significantly higher post-test-result anxiety
(Mean (M) STAI = 31.6 and 30.0, respectively) compared to
those with adequate health literacy (M = 28.6) and no medical
history (M = 28.6), indicating these women might benefit
from extra information and/or guidance when communicating
NIPT test-results. Introducing NIPT as an alternative to inva-
sive testing, led to an offer that satisfied and largely reassured
high-risk pregnant women.
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Introduction
Since 2011, cell-free DNA (cfDNA) testing for the detection
of fetal aneuploidy, also called non-invasive prenatal testing
(NIPT), has become widely available for pregnant women,
including those at elevated risk for aneuploidy based on the
first-trimester combined test (FCT). Until recently, the only
choice for these women was between refraining from further
testing or having invasive testing (amniocentesis or chorionic
villus sampling) to confirm whether their child indeed had an
aneuploidy. Because invasive tests have a small procedure-
related miscarriage risk (Tabor et al. 2010), many women
declined these tests (Nakata et al. 2010), whilst those
accepting testing experienced considerable anxiety (Nakic
Rados et al. 2013; Sarkar et al. 2006). With the introduction
of NIPT, high-risk women are offered a safe and highly sen-
sitive second-tier test (>99% for trisomy 21) (Gil et al. 2015).
Due to the small possibility of false positives, abnormal NIPT
results still need to be confirmed with invasive testing
(Dondorp et al. 2015; ACMG 2013).
Elevated levels of stress and anxiety during pregnancy are
associated with potential adverse obstetrical outcomes such as
preterm delivery and reduced birth weight (Mancuso et al.
2004; Mulder et al. 2002), and are therefore important to
avoid. The mere fact of having a prenatal test for fetal abnor-
malities may affect maternal anxiety (Nakic Rados et al.
2013). Experienced levels of anxiety further increase upon
receiving a high-risk result (Lou et al. 2015). Anxiety is in-
versely correlated with, amongst others, socio-economic sta-
tus (Faisal-Cury et al. 2007), but might be contained by pro-
moting informed choice for testing (Michie et al. 2002).
The safety and non-invasiveness of NIPT, which are seen
as a great advantage by pregnant women (Lewis et al. 2013),
will likely cause less anxiety than a risky invasive test would.
Since NIPT is less accurate than invasive testing, however, a
normal NIPT result might leave women feeling less reassured.
Moreover, NIPT performed using whole-genome sequencing
can lead to fetal and/or maternal secondary findings (Brady
et al. 2016), which might cause uncertainty. Studies amongst
high-risk women undergoing confirmative invasive testing
showed that their high levels of anxiety faded away after
obtaining a normal result (Lou et al. 2015). With regard to
NIPT the literature shows mixed results, with some studies
(Vanstone et al. 2015; Wittman et al. 2016) finding a negative
(favorable) NIPT result is perceived as being reassuring, but
others, although hypothetically addressed (Allyse et al. 2014),
have shown women still want further reassurance through
invasive testing. As part of an implementation study on
NIPT in the UK National Health Service, Lewis et al. (2016)
showed a reduction in elevated anxiety levels from 30% to
14% after NIPT results (most of them being negative) had
been received.
Although several studies on the uptake of NIPT among
high-risk pregnant women have appeared (Chetty et al.
2013; Taylor et al. 2014), more needs to be known about
how women experience the offer of NIPT within a national
prenatal care setting, and if they are satisfied with the proce-
dure. In the UK women at elevated risk who underwent NIPT
in the maternity care pathway of the National Health Services
experienced little regret and were overwhelmingly positive
about NIPT (Lewis et al. 2016). Here we studied Dutch
high-risk women who were offered NIPT as an alternative to
invasive testing within the nationwide TRIDENT study (Trial
by Dutch laboratories for Evaluation of Non-Invasive Prenatal
Testing) (Oepkes et al. 2016). Previously we have shown that
78% of women had made an informed choice for NIPT (van
Schendel et al. 2016). Informed choice is defined as a decision
made with sufficient knowledge, consistent with the decision-
maker’s values and behaviorally implemented (Michie et al.
2002). Informed choice was associated with less decisional
conflict and less pre-test anxiety (van Schendel et al. 2016).
In this part of the study, the following questions were ad-
dressed: 1) How do women experience the NIPT offer and
procedure (e.g. waiting time)? 2) Do women feel reassured
and less anxious after receiving a favorable NIPT result and
which characteristics of women are associated with higher
levels of anxiety? 3) Do women feel satisfied with their choice
for NIPT?, and 4) Who do they think should be offered NIPT
in the future?
Methods
Procedure and Participants
The TRIDENT study evaluated the introduction of NIPT in a
governmentally supported and public healthcare-funded pre-
natal Down syndrome screening program (Oepkes et al.
2016). All women with an elevated risk for fetal aneuploidy
based on FTC (cut-off risk ≥1:200) or based on medical his-
tory (e.g. prior pregnancy with a fetal trisomy) were referred
for further counseling to one of the eight Centers for Prenatal
Diagnosis, or one of their satellite centers. Women were of-
fered a choice between NIPT, invasive testing or no further
testing. Inclusion and exclusion criteria are described else-
where (Oepkes et al. 2016). All women were given oral
counseling by obstetricians, maternal fetal medicine special-
ists or specially trained counselors, and a leaflet. Women were
counseled about test procedures; reporting time; test sensitiv-
ity and specificity for trisomies 21, 18 and 13; and the neces-
sity to confirm abnormal NIPT results with invasive testing.
The miscarriage risk for amniocentesis and chorionic villus
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sampling was mentioned to be 0.3% and 0.5% respectively.
All counselors had followed a nationwide uniform training
program and were certified after passing a test. Patient infor-
mation materials were uniform for all centers. All study infor-
mation was also available online (www.meerovernipt.nl).
Whole-genomemassively parallel sequencing was used for
NIPT. Results were communicated as Bnormal^ result for an-
euploidy (<1:1000 residual risk of aneuploidy, invasive test-
ing not indicated) or Babnormal result^ (high-risk for trisomy
21, 18 or 13, or for other chromosomal abnormalities), requir-
ing confirmation with invasive testing. Results were given
either by telephone, SMS or mail.
During the first five months of the TRIDENT study (April
1st - September 1st 2014) all pregnant women reporting for
counseling because of an elevated FCT risk or medical history
in 7 out of the 8 centers (or their satellite centers) were asked
by their counselor to fill out two questionnaires. The first
questionnaire (Q1) assessed women’s preferences and
decision-making and was filled out at intake after NIPT
counseling. Results have been presented elsewhere (van
Schendel et al. 2016). The second questionnaire (Q2) was
filled out after NIPT or invasive test-results were received.
Outcome of womenwho chose to haveNIPTwill be presented
here. Approval for the study was granted by the Dutch gov-
ernment through a Population Screening Act License (No.
350010–118,701-PG) and by local University Medical
Ethics Committees.
Measures
A combination of validated measures in the questionnaire
were used to measure anxiety as well as questions context-
specific to the TRIDENT study to assess experiences, reassur-
ance and satisfaction that were developed specifically for this
questionnaire for the purpose of informing clinical practice
rather than for explaining a phenomenon. The questionnaires
were designed by a multidisciplinary team of social scientists,
psychologists, obstetricians, and a clinical geneticist.
Experience with Test Offer and Procedure
Women were asked to respond to a statement on the offer of
NIPT: ‘I am happy that NIPT was offered to me’, and on the
time they needed to make a decision about NIPT: ‘I had suf-
ficient time to make my choice about (follow-up) testing’
(completely disagree (1)-completely agree (5)). Both scales
were compressed to a 3-point scale. Women were also asked
if they had a difficult time agreeing about NIPT with their
partner (yes; no; not applicable).
Women were asked how many days they had to wait for
their test-results and how they felt about the length of the
waiting time (way too long (1)-way too short (5)). It was
assessed in what way they had received their test-result, and
how they would have preferred to receive it (answer options:
bymail; by telephone; by email; by SMS; by Patient Portal; by
doctor’s consultation; other).
NIPT Test-Result
Women were asked what their NIPT test-result was (normal
result; abnormal (high-risk) result trisomy 21; trisomy 18; or
trisomy 13; or high-risk result for another chromosomal
abnormality).
Anxiety
Anxiety was measured by a Dutch version of the six-item
short form of the state scale of the Spielberger State-Trait
Anxiety Inventory (STAI) (Marteau & Bekker 1992; van der
Bij et al. 2003). Women were scored on a scale of 20–80,
where higher scores mean higher levels of anxiety. A STAI
score of 34–36 is considered normal anxiety (Bekker et al.
2003), with pregnant women that choose to have a test having
slightly higher STAI scores (Green et al. 2004). Scale reliabil-
ity was good with a Cronbach’s alpha of 0.87.
Child-related anxiety was measured by the subscale ‘fear of
bearing a handicapped child’ (four items) of the Pregnancy-
Related Anxiety Questionnaire-Revised (PRAQ-R scale)
(Huizink et al. 2004). Women scored on a scale of 4–20,
where higher scores mean higher levels of child-related anxi-
ety. Cronbach’s alpha was 0.90.
STAI and PRAQ-R were measured in both questionnaires
to compare levels of anxiety before testing and after receiving
test-results (Q1 and Q2).
Reassurance
Three single-items evaluated whether women felt reassured
by a normal NIPT result: ‘I felt reassured by the test-result’,
‘I am confident that the test-result is correct’ and ‘The test-
result offers me sufficient certainty whether my child has a
disorder’ (not at all applicable (1)-very much applicable (4)).
Women were also asked if they had had confirmative invasive
testing after their normal NIPT result or were considering
doing.
Satisfaction
Women were asked if, retrospectively, they regretted having
had NIPT (not at all applicable (1)-very much applicable (4))
and if they would have preferred to have a test different from
NIPT (yes; no). They were also asked if they would have
preferred to receive test-results earlier in pregnancy (not at
all applicable (1)-very much applicable (4)).
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Future Offer of NIPT
Women were asked to whom they thought NIPT should be
offered (answer options (more than one answer allowed): all
pregnant women irrespective of their risk for aneuploidy;
pregnant women who are at high risk based on the FCT; preg-
nant womenwho are ≥36 years old; pregnant women who had
an earlier pregnancy with aneuploidy; nobody; other).
Women’s Characteristics
The following sociodemographic variables were assessed
(from Q1): age, level of education, ethnicity and religion.
Women were asked to specify their gestational age and parity.
Health literacy was measured by a Dutch version of Chew’s
Set of Brief Screening Questions (SBSQ) (Chew et al. 2004).
Informed decision-making regarding testing with NIPT was
assessed from Q1 (van Schendel et al. 2016) and based on the
Multidimensional Measure of Informed Choice (MMIC)
(Michie et al. 2002).
Data Analysis
Descriptive analyses were used to describe women’s charac-
teristics and responses to statements measuring experiences
with NIPT test offer and procedure, reassurance, satisfaction,
and whom to offer NIPT. Due to non-normal distribution of
the data, Wilcoxon paired signed rank tests were used to mea-
sure the difference in STAI- and PRAQ-R scores at intake
versus after receiving test-results. Amultiple regressionmodel
using analysis of covariance (ANCOVA) (backward elimina-
tion method) looked at the variables associated with higher
‘post-test-result STAI scores’ and higher ‘post-test-result
PRAQ-R scores’, while correcting for the covariates: ‘pre-test
STAI scores’ and ‘pre-test PRAQ-R scores’. All analyses were
performed using SPSS version 20 for Windows (IBM
Statistics for Windows, NY, USA).
Results
Sample Characteristics
In total 708/1253 (response 57%) pregnant women filled out
Q2. Non-response was higher among women with low level
of education and/or inadequate health literacy (p < 0.01), and
among women of non-Western ethnicity compared to Dutch
women (p < 0.01). Thirteen women who had not filled out the
first questionnaire (Q1) were excluded because baseline data
for STAI and PRAQ-R scores were not available, as were
thirteen women who chose to have immediate invasive test-
ing. This resulted in a total sample of 682 women. Women’s
characteristics are presented in Table 1. Mean age was
Table 1 Characteristics of participants, N = 682
Characteristics n (%)
Age (years), missing = 1
≤ 25 11 (1.6)
26–35 285 (41.9)
≥ 36 385 (56.5)
Level of educationa
Low 42 (6.2)
Intermediate 202 (29.6)
High 438 (64.2)
Ethnicityb, missing = 5
Dutch 528 (78.0)
Other Western 75 (11.1)
Non-Western 74 (10.9)
Religionc, missing = 2
None 441 (64.9)
Christian 201 (29.6)
Muslim 16 (2.4)
Other 22 (3.2)
Health literacyd, missing = 1
Inadequate 46 (6.8)
Adequate 635 (93.2)
Gestational age (weeks), missing = 2
10–20 623 (91.6)
20–30 45 (6.6)
30–40 5 (0.7)
No longer pregnant (miscarriage/TOP) 7 (1.0)
Parity, missing = 5
nulliparous 407 (37.7)
multiparous 672 (62.3)
Indication for NIPT, missing = 1
Elevated risk FCT 589 (86.5)
Medical historye 92 (13.5)
A priori risk (FCT risk), missing = 24, NA = 92
≥ 1:10 30 (5.3)
1:11–1:100 267 (47.2)
1:101–1:200 267 (47.2)
Test-result NIPT
Normal result 656 (96.2)
Trisomy 21 14 (2.1)
Trisomy 18 3 (0.4)
Trisomy 13 1 (0.1)
Other trisomy 8 (1.2)
TOP termination of pregnancy, FCT first trimester combined test, NA not
applicable
a Low: elementary school, lower level of secondary school, lower voca-
tional training; Medium: higher level of secondary school, intermediate
vocational training, High: high vocational training, university (Statistics
Netherlands 2016)
b Ethnicity was categorized as Dutch, OtherWestern orNon-Western by the
following algorithm: Dutch if both parents were born in the Netherlands;
OtherWestern if at least one of their parents was born in Europe (excluding
Turkey), North-America, Oceania, Indonesia or Japan; and non-Western if
at least one of their parents was born in Africa, Latin-America, Asia (ex-
cluding Indonesia and Japan) and Turkey. If both parents were born abroad,
then by country of the mother (Statistics Netherlands 2016)
c Christian: Calvinism, Protestantism, Roman-Catholic, Reformed,
Baptism. Other: e.g. Jewish, Hindu, Buddhist
d Inadequate health literacy if answered other than ‘never’ or ‘occasion-
ally’ on one or more items, based on (Chew et al. 2004)
e E.g. a previous child with a trisomy 21, 18 or 13
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35.8 years (range 22–45) and 64.2% were highly educated.
Mean gestational age was 16.9 weeks (range 11–38). For
86.5% the indication for having NIPT was an elevated FCT
risk (≥1:200) and for 13.5% a medical history.
In total, 656 women (96.2%) reported to have received a
normal NIPT result, 14 women (2.1%) reported a high-risk
(abnormal) NIPT result for trisomy 21, three women (0.4%)
for trisomy 18, and one woman (0.1%) for trisomy 13.
Furthermore, eight women (1.2%) received a high-risk result
for other trisomies. At the time of questionnaire completion
(Q2), 14 of these 26 women had had confirmative invasive
testing (details see Supplementary Table S1).
Experiences with Test Offer and Procedure
The vast majority of women (96.1%) stated they were glad to
have been offered NIPT. Most women (85.9%) felt they had
had sufficient time to reflect on their choice. The vast majority
(99.1%) stated that agreeing with their partner about NIPT had
been easy.
The mean number of days women reported to have waited
for their NIPT result was 15 (range 5–32). 68.5% of women
felt that the waiting time was (much) too long and 31.5%
thought it was neither too long nor too short. As shown in
Fig. 1, a waiting time of ≤10 days was considered acceptable
for most women, after this period it was considered too long
by the majority of women. Most women indicated that they
had received their test-results by telephone (51.8%) or by
SMS (23.3%), while 56.1% indicated that telephone was their
preferred way for receiving test-results, and only 9.5% stated
that SMS was their preferred communication medium (see
Supplementary Table S2).
Anxiety
Women with a normal NIPT result had significantly lower
anxiety (STAI) scores after receiving test-results (Mean
(M) = 28.8) compared to the anxiety scores at the moment
of intake (M = 44.3) (Z = −19.52, p < 0.001) (Fig. 2a). For
20 women (3%), anxiety scores were elevated (≥50).
ANCOVA analysis revealed that women’s anxiety scores after
test-results were significantly related to women’s anxiety
scores at intake (p < 0.001), meaning that women who had
more anxiety beforehand were likely to experience higher
anxiety after receiving test-results. The ANCOVA analysis
(Table 2) showed that, when controlling for intake STAI score
(covariate), women with a normal NIPT result who had inad-
equate health literacy showed significantly higher STAI scores
after test-results (M = 31.6) than women with adequate health
literacy (M = 28.6). This was also observed in women who
had NIPT based on a medical indication (M = 30.0)
compared to those with no medical history (M = 28.6). Age,
level of education, a priori risk at FCT and whether or not
women had made an informed choice for NIPT had no effect
on post-test-result STAI scores. Similar results were shown for
child-related anxiety (PRAQ-R) (Table 2). Women with
a normal NIPT result showed a significant decrease in
level of child-related anxiety, with mean PRAQ-R scores of
10.8 at the moment of intake and mean PRAQ-R scores
of 7.8 after receiving test-results (Z = −17.41, p < 0.001) (Fig.
2b).
Overall, the 26 women who had received a high-risk NIPT
result for trisomies 21, 18 or 13 or for other trisomies showed
high anxiety (STAI) scores after receiving test-results
(M = 54.0). For 11 of 14 women who had had confirmatory
Fig. 1 Women’s feelings towards
the time waiting for NIPT results,
N = 682
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invasive testing anxiety levels remained high (M ≥ 50.0) (di-
agnostic testing confirmed that the fetus had a trisomy in 10/
11 women). Due to the low number of women receiving each
type of result, subgroup analyses are not considered
meaningful.
Reassurance after a Normal NIPT Result
Most women who received a normal NIPT result (80.9%)
indicated that the statement ‘I was reassured by the test-result’
very much applied to them, for 15.7% this was somewhat
applicable, and for 3.3% it was not (Table 3). Also most wom-
en (80.9%) felt confidence that the test-result was correct,
while for 18.3% this was somewhat applicable, and for 0.8%
it was not. The statement ‘the test result offers me sufficient
certainty whether my child has a disorder’ was very much
applicable for 64.3% of women, somewhat applicable for
34% of women, and for 1.7% it was not.
Only two out of 656 women with a normal NIPT result
reported to have had confirmatory invasive testing; one be-
cause the NIPT result was considered less reliable due to her
high body weight and the other woman because a fetal anom-
aly was suspected at later ultrasound examination.
Satisfaction
The vast majority of women (97.5%) did not regret having
NIPT. About a third of women (28.6%) very much agreed that
they would have preferred to receive NIPT results earlier in
pregnancy. Of the women receiving a normal NIPT result, 16
(2.4%) would rather have had invasive testing instead of
NIPT; 11 because of the shorter waiting time and five because
of more accurate results. One of the 18 women receiving a
high-risk NIPT result for trisomies 21, 18 or 13 retrospectively
would have preferred invasive testing as a follow up to FCT
screening because of the shorter waiting time, and one woman
would have preferred not to have had follow-up testing. None
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Fig. 2 a Mean STAI scores at intake (Q1) and after receiving a normal
NIPT test-result (Q2),N = 656. *Total STAI score (range 20–80). bMean
PRAQ-R scores at intake (Q1) and after receiving a normal NIPT test-
result (Q2), N = 653. *Total PRAQ-R score calculated with subscale
‘child-related anxiety’ (range 4–20)
Table 2 Multiple regression model using ANCOVA test to identify variables associated with higher post-test-result STAI and PRAQ-R scores in
women with a normal NIPT result
Independent Variables Post-test-result
STAI-score
(n = 320)a
Post-test-result
PRAQ-R-score
(n = 320)a
d.f Mean square F-ratio P-valueb d.f Mean square F-ratio P-valueb
Age 2 57.229 1.029 0.358 2 3.636 0.539 0.584
Level of education 2 5.949 0.120 0.887 2 15.655 2.330 0.099
A priori risk 2 7.448 0.152 0.859 2 7.569 1.247 0.289
Informed choice 1 69.228 1.244 0.265 1 4.047 0.602 0.438
Health literacy 1 220.478 3.961 0.047 1 105.554 15.606 0.000
Medical indication for NIPT 1 359.781 6.463 0.011 1 47.570 7.033 0.008
Covariate:
Pre-test STAI score/Pre-test PRAQ-R score 1 3242.935 58.257 <0.001 1 625.675 92.508 <0.001
STAI State-Trait Anxiety Inventory (Marteau & Bekker 1992; van der Bij et al. 2003), PRAQ-R Pregnancy-Related Anxiety Questionnaire-Revised
(Huizink et al. 2004)
aN = 361 women were excluded from analyses (n = 263 to fit criteria of informed choice analysis (van Schendel et al. 2016) and n = 98 because of
missing values on one of the variables)
b Statistical significance set at p < 0.05
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of the eight women receiving a high-risk NIPT result for other
trisomies stated they would have preferred a different test.
Future Offer of NIPT
Of all women, 54.3% thought that NIPT should be offered to
all pregnant women irrespective of their risk for aneuploidy,
while 36.7% thought that only those at high risk should be
offered NIPT (either based on high-risk FCT (18%), previous
pregnancy with aneuploidy (12.2%) or maternal age (6.5%)).
4.8% mentioned other target groups, for example those who
have a close relative with aneuploidy.
Discussion
This study shows that almost all high-risk pregnant women
were glad to have been offered NIPT and, retrospectively, did
not regret having NIPT, irrespective of NIPT result. The ma-
jority perceived the waiting time for NIPT results (mean
15 days) as (much) too long. After women had received a
normal NIPT result they experienced significantly lower
levels of general anxiety and child-related anxiety compared
to the moment of intake for NIPT. Moreover, the majority of
women felt reassured by the normal NIPT result and were
confident it was correct.
Literature shows that having a high risk for aneuploidy
significantly increases anxiousness in women (Lou et al.
2015), and this was also observed in the women participating
in our study. After women received a normal NIPT result there
was a significant reduction in anxiety to levels considered
normal (Bekker et al., 2003; Green et al. 2004), although for
3% anxiety levels remained high. Residual anxiety in a small
percentage of women has been shown in several studies on
prenatal screening (Green et al. 2004). Most women in our
study indicated they felt reassured by the normal NIPT result,
and similar to the study of Vanstone et al. (2015), women felt
confident the NIPT result was correct. Lewis et al. (2016)
showed that reassurance was the main motivator for women
to accept NIPT. Our study shows that a normal NIPT result is
able to give most women this reassurance, and that the levels
of increased anxiety generated by the high-risk FCT result are
not sustained. The level of anxiety of women with a high-risk
NIPT result for trisomy 21, 18 or 13 or for other trisomies
remained high. The results also showed that some women
with a normal NIPT result were not completely reassured
about the results. At pre-test counseling, information on the
limitations of NIPT was provided, including the residual risk
of aneuploidy. It is therefore not unexpected that some women
are not completely reassured after receiving a normal NIPT
result. Moreover, one third of the women mentioned that
NIPT did not give them sufficient certainty whether their child
has a disorder, possibly indicating that they realize that NIPT
cannot exclude all disorders in their child. A study byWittman
et al. (2016) however, showed that a normal NIPT result gave
many women a false decrease in worry levels for conditions
not screened for by NIPT. It demonstrates the importance to
counsel women about the scope and limitations of NIPT, so
they know how to accurately interpret the result.
Inadequate health literacy and having NIPT based on a
medical indication were associated with less decrease in anx-
iety after receiving a normal NIPT result. Although these
women still showed scores considered to be ‘normal anxiety’,
it can be hypothesized that women with inadequate health
literacy had more residual anxiety because they did not fully
comprehend the test-result that stated that their normal NIPT
result meant that the fetus most likely does not have trisomy
21, 18 of 13. Women with a medical indication (e.g. prior
pregnancy with fetal trisomy) might have more residual anx-
iety because of their previous experience with having an af-
fected child. There was no difference in anxiety levels at
follow-up among women who did or did not make an in-
formed choice for testing.
Similar to our study, Lewis et al. (2016) showed that wom-
en in the UK at increased risk for aneuploidy had a very
positive experience with NIPT. Both studies show that the
long turn-around time is perceived as a limitation. A
Canadian study among women who had NIPT (waiting time
results: 6–21 days) showed that the long waiting time for
NIPT results is considered as very stressful (Vanstone et al.
2015). This is particularly true for women at a later gestational
age who have little time left for a confirmative test in case of a
high-risk NIPT result and a potential termination of pregnan-
cy. Our study indicated that a waiting time for NIPT results up
to ten days is acceptable for most women. Reducing turn-
around time to this period could result in an even more
Table 3 Responses of women with a normal NIPT result (N = 656) to statements about reassurance after NIPT results
Not at all
applicable n (%)
Hardly
applicable n (%)
Somewhat
applicable n (%)
Very much
applicable n (%)
I was reassured by the test-result 16 (2.4) 6 (0.9) 103 (15.7) 530 (80.9)
I am confident that the test-result is correct 1 (0.2) 4 (0.6) 120 (18.3) 531 (80.9)
The test-result offers me sufficient certainty whether my child has a disorder 2 (0.3) 9 (1.4) 223 (34.0) 421 (64.3)
Numbers may not add up to the total due to missing values
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positive experience with NIPT among pregnant high-risk
women. Turn-around time decreased later in the study due to
better equipment (Oepkes et al. 2016).
Test-results were preferably received by telephone and not
by SMS, while almost a quarter of women did receive their
result by SMS. This suggests that, even when results are nor-
mal, women would like a personal conversation with a
healthcare professional, for example to ask additional
questions.
Most women in this study believed that NIPT should be
offered to all pregnant women irrespective of their risk for
aneuploidy, as was also shown in other studies among preg-
nant women (Mikamo et al. 2015; van Schendel et al. 2015)
and health professionals (Tamminga et al. 2015).
Study Limitations and Research Recommendations
The results should be interpreted with some caution since the
response rate to the post-test questionnaire was 57%. Besides
the inability to perform subgroup analyses for women with a
high-risk NIPT result, another limitation of this study is that
there is a possibility of bias since very anxious women might
have refrained from filling out the questionnaire. Moreover,
women with low level of education and/or inadequate literacy
responded less to the second questionnaire. Most women in
our sample had a higher level of education. Dutch women are
shown to be more likely to have prenatal screening if they are
older and have above-average income (Gitsels-van der Wal
et al. 2014). This could be due to the fact that this group often
delays childbearing and are therefore more likely to be at
increased risk for aneuploidy. The strength of this study was
the large sample size and the prospective study design, which
made it possible to study psychological outcomes over time.
More specific research, including qualitative studies, is need-
ed on the psychological effects of receiving a high-risk NIPT
result for chromosomal aberrations other than trisomy 21, 18
and 13.
Conclusion and Practice Implications
Introducing NIPT as an alternative to invasive testing in a
national healthcare-funded prenatal screening program led to
an offer that satisfied high-risk pregnant women. Those who
received a normal result felt largely reassured and their anxiety
levels returned to normal. Reducing waiting time for test-
results is likely to improve women’s experiences with NIPT.
Women who have inadequate health literacy and/or a medical
history (i.e. previous child with aneuploidy) might benefit
from extra explanation, or a more tailored approach or com-
munication aids to support verbal communication, at pre-test
counseling and after receiving normal NIPT results.
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